These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12227126)

  • 1. Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures.
    Guyatt GH; Cranney A; Griffith L; Walter S; Krolicki N; Favus M; Rosen C
    Endocrinol Metab Clin North Am; 2002 Sep; 31(3):659-79, xii. PubMed ID: 12227126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis.
    Cranney A; Guyatt G; Griffith L; Wells G; Tugwell P; Rosen C;
    Endocr Rev; 2002 Aug; 23(4):570-8. PubMed ID: 12202472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What's new in postmenopausal osteoporosis].
    Yodfat Y
    Harefuah; 2007 Feb; 146(2):134-9, 164. PubMed ID: 17352284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
    Harris ST; Watts NB; Genant HK; McKeever CD; Hangartner T; Keller M; Chesnut CH; Brown J; Eriksen EF; Hoseyni MS; Axelrod DW; Miller PD
    JAMA; 1999 Oct; 282(14):1344-52. PubMed ID: 10527181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing osteoporosis-related fractures: an overview.
    Gass M; Dawson-Hughes B
    Am J Med; 2006 Apr; 119(4 Suppl 1):S3-S11. PubMed ID: 16563939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women.
    Cranney A; Wells G; Willan A; Griffith L; Zytaruk N; Robinson V; Black D; Adachi J; Shea B; Tugwell P; Guyatt G;
    Endocr Rev; 2002 Aug; 23(4):508-16. PubMed ID: 12202465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal osteoporosis: Assessment and management.
    Rizzoli R
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):739-757. PubMed ID: 30449552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos).
    Papaioannou A; Joseph L; Ioannidis G; Berger C; Anastassiades T; Brown JP; Hanley DA; Hopman W; Josse RG; Kirkland S; Murray TM; Olszynski WP; Pickard L; Prior JC; Siminoski K; Adachi JD
    Osteoporos Int; 2005 May; 16(5):568-78. PubMed ID: 15517191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents.
    Hochberg MC; Greenspan S; Wasnich RD; Miller P; Thompson DE; Ross PD
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1586-92. PubMed ID: 11932287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis screening of postmenopausal women in the primary care setting: a case-based approach.
    Edwards BJ; Brooks ER; Langman CB
    Gend Med; 2004 Dec; 1(2):70-85. PubMed ID: 16115586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
    Watts NB; Geusens P; Barton IP; Felsenberg D
    J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risedronate for the prevention and treatment of postmenopausal osteoporosis.
    Cranney A; Waldegger L; Zytaruk N; Shea B; Weaver B; Papaioannou A; Robinson V; Wells G; Tugwell P; Adachi JD; Guyatt G
    Cochrane Database Syst Rev; 2003; (4):CD004523. PubMed ID: 14584020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.
    Siris ES; Miller PD; Barrett-Connor E; Faulkner KG; Wehren LE; Abbott TA; Berger ML; Santora AC; Sherwood LM
    JAMA; 2001 Dec; 286(22):2815-22. PubMed ID: 11735756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit-risk assessment of raloxifene in postmenopausal osteoporosis.
    Cranney A; Adachi JD
    Drug Saf; 2005; 28(8):721-30. PubMed ID: 16048357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosis.
    Delmas PD
    Bone; 2002 Jan; 30(1):14-7. PubMed ID: 11792559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment: theoretical considerations.
    Johnston CC; Slemenda CW
    Am J Med; 1993 Nov; 95(5A):2S-5S. PubMed ID: 8256789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of osteoporosis: guidelines for the utilization of bone densitometry.
    Baran DT; Faulkner KG; Genant HK; Miller PD; Pacifici R
    Calcif Tissue Int; 1997 Dec; 61(6):433-40. PubMed ID: 9383266
    [No Abstract]   [Full Text] [Related]  

  • 19. Determinants of incidence of osteoporotic fractures in the female Spanish population older than 50.
    Naves M; Díaz-López JB; Gómez C; Rodríguez-Rebollar A; Cannata-Andía JB
    Osteoporos Int; 2005 Dec; 16(12):2013-7. PubMed ID: 16091836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.
    World Health Organ Tech Rep Ser; 1994; 843():1-129. PubMed ID: 7941614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.